Abstract
Infection of suckling mice with mammalian reovirus type 3 results in fatal encephalitis associated with marked destruction of neurones1–4. The viral tropism specific to neural cells is determined by the reovirus haemagglutinin3,4. This haemagglutinin (HA), the σ1 polypeptide, is encoded in the S1 dsRNA segment5,6. In addition to determining cell and tissue tropism, the viral haemagglutinin determines humoral and cellular immune specificity7–10, binding to cellular micro-tubules11 and inhibition of cellular DNA synthesis12. To elucidate the structural basis for the functions of the reovirus type 3 HA, we have recently isolated and characterized several anti-HA monoclonal antibodies, which we have used to show that there are distinct functional domains on the reovirus type 3 HA13. One group of monoclonal antibodies neutralizes viruses while a second inhibits haemagglutination. Thus there are distinct HA functional domains involving haemagglutination and neutralization. One of the neutralizing monoclonal antibodies was used to select reovirus antigenic variants that were no longer neutralized by the monoclonal antibodies. These ‘variant’ viruses were tested for their neurovirulence by determining their capacity to replicate in mouse brains, leading to fatal encephalitis. We report here that all variants are markedly less virulent then the parental type 3 virus from which they were selected. These findings demonstrate directly the critical role of the viral haemagglutinin in neurovirulence and show that variant viruses that are altered at a site recognized by neutralizing antibody cannot grow efficiently in neural tissue.
Similar content being viewed by others
Article PDF
References
Margolis, G. L., Kilham, L. & Gonatos, N. K. Lab. Invest. 24, 101–109 (1971).
Raine, C. S. & Fields, B. N. J. Neuropath. exp. Neurol. 32, 19–33 (1973).
Weiner, H. L., Drayna, D., Averill, D. R. & Fields, B. N. Proc. natn. Acad. Sci. U.S.A. 74, 5744–5748 (1977).
Weiner, H. K., Powers, M. L. & Fields, B. N. J. infect. Dis. 141, 609–618 (1980).
McCrae, M. A. & Joklik, W. K. Virology 89, 578–593 (1978).
Mustoe, T. A., Ramig, R. F., Sharpe, A. H. & Fields, B. N. Virology 89, 594–604 (1978).
Weiner, H. L. & Fields, B. N. J. exp. Med. 146, 1303–1310 (1977).
Weiner, H. K., Ramig, R. F., Mustoe, T. A. & Fields, B. N. Virology 86, 581–584 (1978).
Finberg, R., Weiner, H. L., Fields, B. N., Benacerraf, B. & Burakoff, S. J. Proc. natn. Acad. Sci. U.S.A. 79, 442–446 (1979).
Finberg, R., Weiner, H. L., Burakoff, S. J. & Fields, B. N. Infect. Immunity 31, 646–649 (1981).
Babiss, L. E. et al. J. Virol. 30, 863–874 (1979).
Sharpe, A. H. & Fields, B. N. J. Virol. 38, 389–392 (1981).
Burstin, S. J., Spriggs, D. R. & Fields, B. N. Virology 117, 146–155 (1982).
Nepom, J. T. et al. J. exp. Med. 155, 155–167 (1982).
Reed, L. J. & Muench, H. Am. J. Hyg. 27, 493–497 (1938).
Ahmed, R. et al. Cell 25, 325–332 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Spriggs, D., Fields, B. Attenuated reovirus type 3 strains generated by selection of haemagglutinin antigenic variants. Nature 297, 68–70 (1982). https://doi.org/10.1038/297068a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/297068a0
This article is cited by
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.